发明名称 Esmolol formulation
摘要 <p>An aqueous, sterile pharmaceutical composition suitable for parenteral administration for the treatment of cardiac conditions, comprising methyl-3-[4-(2-hydroxy-3-isopropylamino) propoxy] phenylpropionate hydrochloride (esmolol hydrochloride), a buffering agent and an osmotic-adjusting agent, as well as a method for its manufacture, are disclosed.</p>
申请公布号 SK12782002(A3) 申请公布日期 2003.11.04
申请号 SK20020001278 申请日期 2002.01.02
申请人 BAXTER INTERNATIONAL INC. 发明人 LIU JIE;PEJAVER SATISH K.;OWOO GEORGE
分类号 A61K9/08;A61K9/00;A61K31/215;A61K31/216;A61K31/24;A61K47/02;A61K47/12;A61K47/18;A61K47/24;A61K47/26;A61P9/00;A61P9/10;A61P43/00;(IPC1-7):A61K31/215 主分类号 A61K9/08
代理机构 代理人
主权项
地址